vTv Therapeutics, Inc. (VTVT)
33.89
+0.64
(+1.91%)
USD |
NASDAQ |
Aug 24, 16:00
33.61
-0.28
(-0.83%)
After-Hours: 20:00
vTv Therapeutics Price to Book Value : 1.698 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.698 |
| August 21, 2026 | 1.666 |
| August 20, 2026 | 1.657 |
| August 19, 2026 | 1.648 |
| August 18, 2026 | 1.577 |
| August 17, 2026 | 1.568 |
| August 14, 2026 | 1.509 |
| August 13, 2026 | 1.545 |
| August 12, 2026 | 1.592 |
| August 11, 2026 | 1.655 |
| August 10, 2026 | 1.718 |
| August 07, 2026 | 1.772 |
| August 06, 2026 | 1.734 |
| August 05, 2026 | 1.723 |
| August 04, 2026 | 1.606 |
| August 03, 2026 | 1.622 |
| July 31, 2026 | 1.620 |
| July 30, 2026 | 1.637 |
| July 29, 2026 | 1.577 |
| July 28, 2026 | 1.557 |
| July 27, 2026 | 1.554 |
| July 24, 2026 | 1.539 |
| July 23, 2026 | 1.586 |
| July 22, 2026 | 1.586 |
| July 21, 2026 | 1.648 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.622 |
| July 17, 2026 | 1.647 |
| July 16, 2026 | 1.618 |
| July 15, 2026 | 1.638 |
| July 14, 2026 | 1.597 |
| July 13, 2026 | 1.582 |
| July 10, 2026 | 1.678 |
| July 09, 2026 | 1.675 |
| July 08, 2026 | 1.735 |
| July 07, 2026 | 1.709 |
| July 06, 2026 | 1.730 |
| July 02, 2026 | 1.773 |
| July 01, 2026 | 1.756 |
| June 30, 2026 | 1.886 |
| June 29, 2026 | 1.588 |
| June 26, 2026 | 1.536 |
| June 25, 2026 | 1.612 |
| June 24, 2026 | 1.565 |
| June 23, 2026 | 1.547 |
| June 22, 2026 | 1.485 |
| June 18, 2026 | 1.534 |
| June 17, 2026 | 1.485 |
| June 16, 2026 | 1.412 |
| June 15, 2026 | 1.468 |
| June 12, 2026 | 1.435 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Spyre Therapeutics, Inc. | 9.838 |
| ACADIA Pharmaceuticals, Inc. | 3.906 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Anika Therapeutics, Inc. | 2.080 |
| Savara, Inc. | 7.949 |
Price to Book Value Related Metrics
| PS Ratio | 10.93 |
| Price | 33.89 |
| Earnings Yield | -3.12% |
| Market Cap | 133.49M |